390 related articles for article (PubMed ID: 15492270)
1. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
2. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
3. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
Zhang XA; He B; Zhou B; Liu L
J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
[TBL] [Abstract][Full Text] [Related]
4. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
5. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
[TBL] [Abstract][Full Text] [Related]
6. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
Sridhar SC; Miranti CK
Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation.
Delaguillaumie A; Harriague J; Kohanna S; Bismuth G; Rubinstein E; Seigneuret M; Conjeaud H
J Cell Sci; 2004 Oct; 117(Pt 22):5269-82. PubMed ID: 15454569
[TBL] [Abstract][Full Text] [Related]
8. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
9. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
[TBL] [Abstract][Full Text] [Related]
10. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
[TBL] [Abstract][Full Text] [Related]
11. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
[TBL] [Abstract][Full Text] [Related]
12. KAI1 tetraspanin and metastasis suppressor.
Jackson P; Marreiros A; Russell PJ
Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
[TBL] [Abstract][Full Text] [Related]
13. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
White A; Lamb PW; Barrett JC
Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
[TBL] [Abstract][Full Text] [Related]
14. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway.
Jee B; Jin K; Hahn JH; Song HG; Lee H
Exp Mol Med; 2003 Feb; 35(1):30-7. PubMed ID: 12642901
[TBL] [Abstract][Full Text] [Related]
16. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
[TBL] [Abstract][Full Text] [Related]
18. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
[TBL] [Abstract][Full Text] [Related]
19. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
20. CD82, and CD63 in thyroid cancer.
Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
